VIVONasdaqinactive

MERIDIAN BIOSCIENCE INC

Technology·Infectious Disease·Commercial·London, United Kingdom
Infectious Disease

MERIDIAN BIOSCIENCE INC (VIVO): 7 pipeline candidates · ~144 mo cash runway. Updated within the last hour.

10.0/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway10.0

143.5 months

Financial Health9.9

0% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth10.0

7 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for MERIDIAN BIOSCIENCE INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$99.6M

Cash

$74.1M

Quarterly Burn

$2.3M

Runway

143.5 mo

Revenue

$56.9M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jun 2038
Today~158 mo out
Catalyst within runway

Pipeline (7 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

26

Total value held

$1.2M

HolderSharesValue
jane street group, llc168,603$388K
susquehanna international group, llp83,219$191K
bbr partners, llc53,566$123K
marex group plc39,754$91K
citadel advisors llc39,100$90K
renaissance technologies llc25,400$58K
citizens financial group inc/ri20,000$46K
j. derek lewis & associates inc.20,000$45K
millennium management llc19,169$44K
morgan stanley15,655$36K

Showing top 10 of 26 institutional holders of MERIDIAN BIOSCIENCE INC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Tser Fah Chin

Frequently asked questions

How many drug candidates are in MERIDIAN BIOSCIENCE INC's pipeline?

MERIDIAN BIOSCIENCE INC (VIVO) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is MERIDIAN BIOSCIENCE INC's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, MERIDIAN BIOSCIENCE INC has approximately 143.5 months of cash runway.

What is MERIDIAN BIOSCIENCE INC's market capitalization?

MERIDIAN BIOSCIENCE INC's market capitalization is approximately $99.6M.

Who is the CEO of MERIDIAN BIOSCIENCE INC?

Mr. Tser Fah Chin is the chief executive officer of MERIDIAN BIOSCIENCE INC (VIVO).

Get the full picture on MERIDIAN BIOSCIENCE INC

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.